en
E-mail us
(925) 558-5040
bd_global@crystalpharmatech.com
 cn
cn
Knowledge Hub Explore
Detecting Low-Level Crystallinity in ASD-like Samples Using ssNMR Techniques Whitepaper Detecting Low-Level Crystallinity in ASD-like Samples Using ssNMR Techniques
Solid Form Landscape to Formulation Strategy: The role of computational screening and risk assessment Technical Insight Solid Form Landscape to Formulation Strategy: The role of computational screening and risk assessment
Determination and Control of Crystal Form in ASD Formulations: A Case Study on Everolimus Tablets Whitepaper Determination and Control of Crystal Form in ASD Formulations: A Case Study on Everolimus Tablets
Webinar Series Explore
Solid Form Landscape to Formulation Strategy: The Role of Computational Screening and Risk Assessment Crystal Pharmatech Formulation Forum Solid Form Landscape to Formulation Strategy: The Role of Computational Screening and Risk Assessment
Applying PBPK and PBBM Across R&D: From Early Insights to Formulation Crystal Pharmatech Formulation Forum Applying PBPK and PBBM Across R&D: From Early Insights to Formulation
Patient-Centered Controlled and Modified Release Drug Delivery: Formulation & Process Development Crystal Pharmatech Formulation Forum Patient-Centered Controlled and Modified Release Drug Delivery: Formulation & Process Development
Events Explore
San Diego Biotech Reception: Cocktails & Conversations with Crystal Pharmatech
Events
San Diego Biotech Reception: Cocktails & Conversations with Crystal Pharmatech
February 24, 2026
Events
Meet Crystal Pharmatech at DCAT Week 2026
March 23-26, 2026
Events
Meet Crystal Bio Solutions at WCBP 2026 Booth 18
January 27-29, 2026
Events
AAPS PharmSci 360
November 9–12, 2025
News Explore
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
News
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
28 Jan 2026
Brise Pharma Presents“Best Partner”Trophy to Crystal Formulation Services, Recognizing Their Excellence in Drug Product CDMO Services
04 Dec 2025
Crystal Pharmatech Receives CNAS Reaccreditation, Scope Expansion, and Address Approval
11 Aug 2025
Crystal Pharmatech and Divamics Announce Strategic Collaboration to Accelerate Drug Development through AI, Crystal Form, and Formulation Innovation
09 May 2025
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Crystal NAX
DNA Synthesis RNA Synthesis LNP Formulation Services Analytical & Characterization Services Early-Phase Manufacturing Catalogue Products
Technology
Solid Form Screening Solid Form Developability Evaluation Absolute Structure Determination Crystallization Process Development Conventional Oral Solid Dosage Forms Bioavailability Enhancement for Insoluble Compounds & PROTAC & Oral Peptides Mini-tablet
Quick Links
Highlights News Events Knowledge Hub Webinar Series
Contact Us
bd_global@crystalpharmatech.com (925) 558-5040
U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123

Subscribe to be the first to get the updates!

Subscribe to be the first to get the updates!
Privacy Policy
Sitemap
Small Molecule
Mol2Med™ Integrated Services Developability Assessment API Form and Solid-State Research Crystallization Development Services Pre-formulation Studies Formulation and Analytical Development GMP Manufacturing Clinical Supply
Crystal Bio Solutions
Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Technology
Quick Links
About Us Events
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
bd_global@crystalpharmatech.com (925) 558-5040
Privacy Policy
Sitemap